Evidence review

BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-vs-nsaids-comparison`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-vs-nsaids-comparison

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair

What is this peptide/stack/condition?

BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.

Who claims what — study authors, platforms, n=?

User contrasts NSAIDs damaging gut lining with BPC-157 repairing it, highlighting protective/repairing benefits of BPC over NSAIDs.

Direct comparison: BPC-157 repairs NSAID gut damage (anecdotal, not advice).

X post (anecdotal experience shared): BPC-157 vs NSAID gut damage; user reports reduced bloating after 2 weeks oral 250-500mcg daily (anecdotal, not advice).

X post compares BPC-157 repair to NSAID damage; notes oral use for gut (anecdotal).

X post compares mechanisms: BPC-157 resolves vs NSAIDs suppress inflammation; focuses on gut repair from NSAID damage. No dosing anecdotes here.

X post recommends oral BPC-157 specifically for gut damage/NSAID inflammation; differentiates from injectable. Anecdotal context on use.

X post highlights BPC-157 restoring gut barrier amid NSAID use (positive repair anecdote/research).

X post lists BPC-157 reversing NSAID gut damage per study (anecdotal research summary).

Similar X post emphasizing BPC-157 reversal of NSAID gut damage.

X post summarizing BPC-157 benefits for NSAID gut damage (research-focused, not personal anecdote).

Reddit user discussion advising against concurrent NSAID use with BPC-157 due to its protective/reversing effects on GI damage.

Anecdotal advice on timing peptides separately from NSAIDs to avoid interference.

Anecdotal reports of combining BPC-157 with NSAIDs for pain without negative interactions, some noting additive effects.

User comment suggesting replacing ibuprofen (NSAID) with BPC-157 for sciatica recovery, implying better outcomes without NSAID side effects.

User reports positive healing for injuries/pain (potentially inflammatory) with BPC-157 stack, no negatives mentioned beyond cost; contrasts implicitly with ongoing NSAID use in community.

User discusses potential interactions between BPC-157 and ongoing NSAID use for chronic inflammation.

Anecdotal reports suggest BPC-157 may reduce NSAID-induced gut damage, but these claims lack rigorous scientific validation.

User reports successful gut repair from NSAID (aspirin) damage with oral BPC-157; benefits persisted after stopping if no new damage; mixed results from others on duration.

Positive but partial IBS-D improvement with BPC-157 that partially persisted off-cycle.

User with NSAID-induced gastritis reports significant symptom improvement and tolerance to triggers after oral + subq BPC-157; notes partial attribution to prior antibiotics.

Another user reports substantial reduction in gastritis/GERD symptoms after ~1 month of BPC-157.

User reports excellent results healing ulcers and gastritis with low-dose oral BPC-157, contrasting with NSAID damage; notes side effects at higher doses.

Bad outcome: severe adverse reaction (panic, vomiting, depression) while using BPC-157 for IBS-D, no significant IBS improvement.

Positive user experience: subQ BPC-157 resolved perceived IBS symptoms allowing normal eating, with some recurrence post-cycle.

Good outcome: BPC-157 rapidly healed NSAID (aspirin + steroids) induced stomach ulcers when prescribed by doctor.

Positive long-term oral BPC-157 experience for gut repair (bloating, post-meal pain), no side effects reported.

User noted rapid resolution of long-standing stomach ulcer symptoms after starting BPC-157 dosing.

A Reddit user discusses their experience or opinion regarding BPC-157 and NSAIDs.

A Reddit user discusses BPC-157, TB500, and anti-inflammatory drugs, potentially sharing personal experiences or observations.

Anecdotal research guide notes BPC-157 counteracts NSAID gut damage independently (anecdotal, not advice).

User seeking BPC-157 for gut repair possibly related to NSAID/GERD issues (anecdotal, not advice).

Discussion on BPC-157 for gut protection, implied vs NSAID damage (anecdotal, not advice).

Positive anecdotal outcome for gut healing; another notes 3-month course loved it (anecdotal, not advice).

Inquiry into BPC-157 for gut/IBS repair (anecdotal context, not advice).

Post summarizes research on BPC-157 protecting against NSAID ulcers and gut damage; notes oral effectiveness for GI (anecdotal context).

AMA discusses BPC-157 history and gut protection from NSAIDs; user comments reference healing effects (anecdotal).

Thread on BPC-157 for gut health and anti-inflammation; mentions NSAID context indirectly via healing (anecdotal dosing notes).

User reports stomach lining damage from long-term NSAID (ibuprofen) use and anecdotal positive experience with BPC-157 for recovery. Good outcome noted anecdotally, not advice.

Thread comparing peptides for gut issues including implied NSAID context; notes BPC-157's repair role. Anecdotal experiences may be in comments but not detailed here.

Anecdotal report of rapid gut improvement (better eating tolerance, mood) from BPC-157 use; other comments note resolved acid reflux/bloat, IBS relief, but some recurrence after stopping (anecdotal, not advice).

Anecdotal positive outcome: BPC-157 resolved long-term stomach issues including acid reflux and bloating during/after use for shoulder injury (anecdotal, not advice).

Anecdotal success story: sublingual/oral BPC-157 (500 mcg daily) eliminated IBS symptoms for over a month with no side effects (anecdotal, not advice).

Mixed anecdotal outcomes: positive for some with IBS, no improvement or negative responses reported by others (anecdotal, not advice).

Anecdotal/research summary on X: BPC-157 protects against NSAID-induced stomach damage and aids gut repair (anecdotal claims, not advice).

User reports switching from daily high-dose ibuprofen to peptides, implying gut/pain management benefits (anecdotal, not advice).

User anecdotal report of improved gut health while on BPC-157 (good outcome, labeled anecdotal).

Comment reports side effect of stomach pain and constipation from BPC-157 dosing (bad outcome, anecdotal).

Anecdotal post promoting oral BPC-157 (250-500 mcg daily, 4-6 weeks) for repairing GI lining and reducing gut inflammation; labels as general info not advice. No direct ibuprofen comparison but focuses on gut repair.

User comment notes ibuprofen stomach bleed risk and reports BPC-157 helped with pain (anecdotal, not advice).

Post highlights BPC-157 for healing/preventing NSAID-induced gastric damage (anecdotal context).

Promotes BPC-157 for NSAID gut repair based on studies; user mentions personal use but no specific bad outcomes or dosing anecdotes here.

Anecdotal reports summarized: gut healing in days, blocking ibuprofen damage. Labeled anecdotal, not advice. No specific side effects or dosing details.

Focuses on BPC-157 repairing NSAID-induced multi-organ damage including gut; personal testimonial implied but not detailed.

Anecdotal framing around rapid NSAID gut repair with BPC-157; emphasizes protection from ibuprofen damage.

Anecdotal discussion on using injectable BPC-157 for gut issues like IBS pain and bloating when oral causes reactions (possibly from fillers). Users report it works systemically; one notes lasting benefits after cycling with KPV, improved digestion. (Anecdotal, not advice).

Anecdotal report of complete gut repair (issues unspecified but resolved) with oral then subq BPC-157 + KPV; one cycle sufficient, worried about angiogenic effects due to family cancer history. (Anecdotal, not advice).

Thread highlights BPC-157 restoring tight junctions (claudin, occludin, ZO-1) in NSAID-induced leaky gut models, plus gut-brain axis benefits. Notes oral for gut targeting. (Research summary + anecdotal context).

X thread discusses how NSAIDs like ibuprofen damage gut (reducing natural BPC-157 repair signal), leading to stalled healing/scarring; promotes BPC-157 for actual repair including NSAID protection. Multiple replies in thread. (Anecdotal/research mix).

Anecdotal report of BPC-157 (in blend) helping IBS/GI issues potentially related to NSAID damage; user notes reduced urgency/anxiety around eating. Dosing: 250mcg daily (anecdotal, not advice). Positive GI outcome mentioned.

User attributes worsened GERD/GI issues to ibuprofen (NSAID), reports BPC-157 (oral, 2 caps AM/PM) helping healing lining/esophagus and reducing symptoms; positive outcome but notes need to continue other supports. Anecdotal.

Thread discusses potential interference of ibuprofen (NSAID) with BPC-157 healing; mixed anecdotal mentions of gut tolerance issues. Label as anecdotal, not advice.

X post mentions BPC-157 improving gut urgency/bloating (possibly NSAID-related context); positive anecdotal outcome for GI repair. Dosing not specified (anecdotal, not advice).

User anecdote: Started BPC-157 (anecdotal, not advice) to continue NSAID use; reported improved gut and major pain relief in hip injury. Labeled as personal experience only.

User reports stopping daily ibuprofen after starting BPC-157/TB500 stack (anecdotal); pain relief noted. Another user mentions similar stack success. Anecdotal only.

User tried ibuprofen unsuccessfully for tendinosis; planning oral BPC-157 (anecdotal dosing/experience, not advice).

User used higher dose BPC-157 for shoulder issue noting its gut healing origins (anecdotal, not advice).

What is known with tier labels (human/preclinical/anecdotal)

2020 review detailing BPC-157's cytoprotective effects against NSAID-induced intestinal permeability issues and gastroenteropathy.

2013 review positioning BPC-157 as a potential NSAID antidote due to counteraction of GI, liver, brain lesions, bleeding, and other side effects.

Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.

2025 review citing BPC-157's cytoprotective effects against NSAID gut damage via permeability stabilization.

2024 review on BPC-157 for intestinal healing, referencing NSAID contexts in related work.

2017 study showing BPC-157 consistently antagonizes NSAID-induced sphincter pressure drops (diclofenac, ibuprofen, etc.).

2021 review discusses BPC-157's counteraction of NSAID toxicity alongside wound healing effects.

2025 review discussing BPC-157 NSAID rescue in gut contexts.

2022 review highlighting BPC-157 counteraction of NSAID GI lesions.

In rat studies BPC-157 reduced NSAID-induced GI lesions from indomethacin, aspirin, diclofenac

BPC 157 strongly antagonizes diclofenac-induced GI, liver, and brain toxicity in rats, acting as an antidote to NSAID side effects.

What is NOT known — explicit gaps

No human trials evaluate BPC-157 for NSAID-induced gut damage reversal

There is a lack of long-term studies on the effects of BPC-157 on NSAID-induced gut damage.

Discussion on combining BPC-157 with daily low-dose aspirin (NSAID); notes potential gut protective benefit against NSAID damage but cautions no human data, possible bleeding risk. Anecdotal suggestions to space doses (not advice).

Proposed mechanism (mechanistic tier only)

BPC-157 promotes angiogenesis and gut lining repair in animal models

NSAIDs inhibit COX enzymes to reduce pain and inflammation but can damage GI mucosa and impair healing

Limits of evidence — no dose advice

User discussion on potential interaction where NSAIDs like ibuprofen may counteract BPC-157 healing benefits.

Not medical advice

Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.

NSAIDs · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpAOD 9604 for NsaidsARA 290 for NsaidsNsaidsBPC 157 for Nsaids
Evidence · 85 sources · swipe →chain 1ad07aaf3b35 · verify chain · provenance
1 / 85
Evidence ledger 88 · tier-ranked · API
anecdotal
User discussion on potential interaction where NSAIDs like ibuprofen may counteract BPC-157 healing benefits.
sources: s13
human
No human trials evaluate BPC-157 for NSAID-induced gut damage reversal
sources: s4
human
2020 review detailing BPC-157's cytoprotective effects against NSAID-induced intestinal permeability issues and gastroenteropathy.
sources: s5
human
2013 review positioning BPC-157 as a potential NSAID antidote due to counteraction of GI, liver, brain lesions, bleeding, and other side effects.
sources: s6
human
Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.
sources: s12, s15, s26, s4, s43
80 more ranked claims
human0.80
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.80
There is a lack of long-term studies on the effects of BPC-157 on NSAID-induced gut damage.
kimi/moonshot-v1-8k
This claim addresses the absence of long-term studies, which is a significant gap in the current understanding of BPC-157's effects on NSAID-induced gut damage.
sources: s4
human0.80
2025 review citing BPC-157's cytoprotective effects against NSAID gut damage via permeability stabilization.
grok/grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
human0.80
2024 review on BPC-157 for intestinal healing, referencing NSAID contexts in related work.
grok/grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
preclinical0.50
BPC-157 promotes angiogenesis and gut lining repair in animal models
system/repair
Core mapping to NSAID damage
sources: s1
preclinical0.50
2017 study showing BPC-157 consistently antagonizes NSAID-induced sphincter pressure drops (diclofenac, ibuprofen, etc.).
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
system0.35
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
mechanistic0.30
NSAIDs inhibit COX enzymes to reduce pain and inflammation but can damage GI mucosa and impair healing
system/repair
Establishes baseline problem framing
anecdotal0.30
User contrasts NSAIDs damaging gut lining with BPC-157 repairing it, highlighting protective/repairing benefits of BPC over NSAIDs.
grok/grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.30
Direct comparison: BPC-157 repairs NSAID gut damage (anecdotal, not advice).
grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
anecdotal0.30
X post (anecdotal experience shared): BPC-157 vs NSAID gut damage; user reports reduced bloating after 2 weeks oral 250-500mcg daily (anecdotal, not advice).
grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.30
X post compares BPC-157 repair to NSAID damage; notes oral use for gut (anecdotal).
grok-4.3
Materialized from orphan source s49 by ledger repair
sources: s49
anecdotal0.30
X post compares mechanisms: BPC-157 resolves vs NSAIDs suppress inflammation; focuses on gut repair from NSAID damage. No dosing anecdotes here.
grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
anecdotal0.30
X post recommends oral BPC-157 specifically for gut damage/NSAID inflammation; differentiates from injectable. Anecdotal context on use.
grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
anecdotal0.30
X post highlights BPC-157 restoring gut barrier amid NSAID use (positive repair anecdote/research).
grok-4.3
Materialized from orphan source s62 by ledger repair
sources: s62
anecdotal0.30
X post lists BPC-157 reversing NSAID gut damage per study (anecdotal research summary).
grok-4.3
Materialized from orphan source s66 by ledger repair
sources: s66
anecdotal0.30
Similar X post emphasizing BPC-157 reversal of NSAID gut damage.
grok-4.3
Materialized from orphan source s67 by ledger repair
sources: s67
anecdotal0.30
X post summarizing BPC-157 benefits for NSAID gut damage (research-focused, not personal anecdote).
grok-4.3
Materialized from orphan source s85 by ledger repair
sources: s85
human0.22low confidence
2021 review discusses BPC-157's counteraction of NSAID toxicity alongside wound healing effects.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
human0.22low confidence
2025 review discussing BPC-157 NSAID rescue in gut contexts.
grok/grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
human0.22low confidence
2022 review highlighting BPC-157 counteraction of NSAID GI lesions.
grok/grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
preclinical0.22low confidence
In rat studies BPC-157 reduced NSAID-induced GI lesions from indomethacin, aspirin, diclofenac
system/repair
Direct evidence separation from human data
sources: s2, s3
preclinical0.22low confidence
BPC 157 strongly antagonizes diclofenac-induced GI, liver, and brain toxicity in rats, acting as an antidote to NSAID side effects.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
Reddit user discussion advising against concurrent NSAID use with BPC-157 due to its protective/reversing effects on GI damage.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Anecdotal advice on timing peptides separately from NSAIDs to avoid interference.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
Anecdotal reports of combining BPC-157 with NSAIDs for pain without negative interactions, some noting additive effects.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
User comment suggesting replacing ibuprofen (NSAID) with BPC-157 for sciatica recovery, implying better outcomes without NSAID side effects.
grok/grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
User reports positive healing for injuries/pain (potentially inflammatory) with BPC-157 stack, no negatives mentioned beyond cost; contrasts implicitly with ongoing NSAID use in community.
grok/grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User discusses potential interactions between BPC-157 and ongoing NSAID use for chronic inflammation.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22low confidence
Anecdotal reports suggest BPC-157 may reduce NSAID-induced gut damage, but these claims lack rigorous scientific validation.
kimi/moonshot-v1-8k
This claim explicitly names anecdotal sources claiming BPC-157's protective effects against NSAID-induced gut damage, which were previously unattributed in the ledger.
sources: s8, s9
anecdotal0.22low confidence
User reports successful gut repair from NSAID (aspirin) damage with oral BPC-157; benefits persisted after stopping if no new damage; mixed results from others on duration.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
Positive but partial IBS-D improvement with BPC-157 that partially persisted off-cycle.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
User with NSAID-induced gastritis reports significant symptom improvement and tolerance to triggers after oral + subq BPC-157; notes partial attribution to prior antibiotics.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
Another user reports substantial reduction in gastritis/GERD symptoms after ~1 month of BPC-157.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User reports excellent results healing ulcers and gastritis with low-dose oral BPC-157, contrasting with NSAID damage; notes side effects at higher doses.
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22low confidence
Bad outcome: severe adverse reaction (panic, vomiting, depression) while using BPC-157 for IBS-D, no significant IBS improvement.
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
Positive user experience: subQ BPC-157 resolved perceived IBS symptoms allowing normal eating, with some recurrence post-cycle.
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
Good outcome: BPC-157 rapidly healed NSAID (aspirin + steroids) induced stomach ulcers when prescribed by doctor.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
Positive long-term oral BPC-157 experience for gut repair (bloating, post-meal pain), no side effects reported.
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
User noted rapid resolution of long-standing stomach ulcer symptoms after starting BPC-157 dosing.
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
A Reddit user discusses their experience or opinion regarding BPC-157 and NSAIDs.
gemini-collaborator
Materializes an orphan anecdotal source, providing insight into user discussions.
sources: s8
anecdotal0.22low confidence
A Reddit user discusses BPC-157, TB500, and anti-inflammatory drugs, potentially sharing personal experiences or observations.
gemini-collaborator
Materializes another orphan anecdotal source, reflecting online community discussions.
sources: s9
anecdotal0.22low confidence
Anecdotal research guide notes BPC-157 counteracts NSAID gut damage independently (anecdotal, not advice).
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
anecdotal0.22low confidence
User seeking BPC-157 for gut repair possibly related to NSAID/GERD issues (anecdotal, not advice).
grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
anecdotal0.22low confidence
Discussion on BPC-157 for gut protection, implied vs NSAID damage (anecdotal, not advice).
grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
anecdotal0.22low confidence
Positive anecdotal outcome for gut healing; another notes 3-month course loved it (anecdotal, not advice).
grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
Inquiry into BPC-157 for gut/IBS repair (anecdotal context, not advice).
grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
Post summarizes research on BPC-157 protecting against NSAID ulcers and gut damage; notes oral effectiveness for GI (anecdotal context).
grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
anecdotal0.22low confidence
AMA discusses BPC-157 history and gut protection from NSAIDs; user comments reference healing effects (anecdotal).
grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Thread on BPC-157 for gut health and anti-inflammation; mentions NSAID context indirectly via healing (anecdotal dosing notes).
grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
anecdotal0.22low confidence
User reports stomach lining damage from long-term NSAID (ibuprofen) use and anecdotal positive experience with BPC-157 for recovery. Good outcome noted anecdotally, not advice.
grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
anecdotal0.22low confidence
Thread comparing peptides for gut issues including implied NSAID context; notes BPC-157's repair role. Anecdotal experiences may be in comments but not detailed here.
grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.22low confidence
Anecdotal report of rapid gut improvement (better eating tolerance, mood) from BPC-157 use; other comments note resolved acid reflux/bloat, IBS relief, but some recurrence after stopping (anecdotal, not advice).
grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Anecdotal positive outcome: BPC-157 resolved long-term stomach issues including acid reflux and bloating during/after use for shoulder injury (anecdotal, not advice).
grok-4.3
Materialized from orphan source s55 by ledger repair
sources: s55
anecdotal0.22low confidence
Anecdotal success story: sublingual/oral BPC-157 (500 mcg daily) eliminated IBS symptoms for over a month with no side effects (anecdotal, not advice).
grok-4.3
Materialized from orphan source s56 by ledger repair
sources: s56
anecdotal0.22low confidence
Mixed anecdotal outcomes: positive for some with IBS, no improvement or negative responses reported by others (anecdotal, not advice).
grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
anecdotal0.22low confidence
Anecdotal/research summary on X: BPC-157 protects against NSAID-induced stomach damage and aids gut repair (anecdotal claims, not advice).
grok-4.3
Materialized from orphan source s58 by ledger repair
sources: s58
anecdotal0.22low confidence
User reports switching from daily high-dose ibuprofen to peptides, implying gut/pain management benefits (anecdotal, not advice).
grok-4.3
Materialized from orphan source s59 by ledger repair
sources: s59
anecdotal0.22low confidence
User anecdotal report of improved gut health while on BPC-157 (good outcome, labeled anecdotal).
grok-4.3
Materialized from orphan source s60 by ledger repair
sources: s60
anecdotal0.22low confidence
Comment reports side effect of stomach pain and constipation from BPC-157 dosing (bad outcome, anecdotal).
grok-4.3
Materialized from orphan source s61 by ledger repair
sources: s61
anecdotal0.22low confidence
Anecdotal post promoting oral BPC-157 (250-500 mcg daily, 4-6 weeks) for repairing GI lining and reducing gut inflammation; labels as general info not advice. No direct ibuprofen comparison but focuses on gut repair.
grok-4.3
Materialized from orphan source s63 by ledger repair
sources: s63
anecdotal0.22low confidence
User comment notes ibuprofen stomach bleed risk and reports BPC-157 helped with pain (anecdotal, not advice).
grok-4.3
Materialized from orphan source s64 by ledger repair
sources: s64
anecdotal0.22low confidence
Post highlights BPC-157 for healing/preventing NSAID-induced gastric damage (anecdotal context).
grok-4.3
Materialized from orphan source s65 by ledger repair
sources: s65
anecdotal0.22low confidence
Promotes BPC-157 for NSAID gut repair based on studies; user mentions personal use but no specific bad outcomes or dosing anecdotes here.
grok-4.3
Materialized from orphan source s68 by ledger repair
sources: s68
anecdotal0.22low confidence
Anecdotal reports summarized: gut healing in days, blocking ibuprofen damage. Labeled anecdotal, not advice. No specific side effects or dosing details.
grok-4.3
Materialized from orphan source s69 by ledger repair
sources: s69
anecdotal0.22low confidence
Focuses on BPC-157 repairing NSAID-induced multi-organ damage including gut; personal testimonial implied but not detailed.
grok-4.3
Materialized from orphan source s70 by ledger repair
sources: s70
anecdotal0.22low confidence
Anecdotal framing around rapid NSAID gut repair with BPC-157; emphasizes protection from ibuprofen damage.
grok-4.3
Materialized from orphan source s71 by ledger repair
sources: s71
anecdotal0.22low confidence
Anecdotal discussion on using injectable BPC-157 for gut issues like IBS pain and bloating when oral causes reactions (possibly from fillers). Users report it works systemically; one notes lasting benefits after cycling with KPV, improved digestion. (Anecdotal, not advice).
grok-4.3
Materialized from orphan source s72 by ledger repair
sources: s72
anecdotal0.22low confidence
Anecdotal report of complete gut repair (issues unspecified but resolved) with oral then subq BPC-157 + KPV; one cycle sufficient, worried about angiogenic effects due to family cancer history. (Anecdotal, not advice).
grok-4.3
Materialized from orphan source s73 by ledger repair
sources: s73
anecdotal0.22low confidence
Thread highlights BPC-157 restoring tight junctions (claudin, occludin, ZO-1) in NSAID-induced leaky gut models, plus gut-brain axis benefits. Notes oral for gut targeting. (Research summary + anecdotal context).
grok-4.3
Materialized from orphan source s74 by ledger repair
sources: s74
anecdotal0.22low confidence
X thread discusses how NSAIDs like ibuprofen damage gut (reducing natural BPC-157 repair signal), leading to stalled healing/scarring; promotes BPC-157 for actual repair including NSAID protection. Multiple replies in thread. (Anecdotal/research mix).
grok-4.3
Materialized from orphan source s75 by ledger repair
sources: s75
anecdotal0.22low confidence
Anecdotal report of BPC-157 (in blend) helping IBS/GI issues potentially related to NSAID damage; user notes reduced urgency/anxiety around eating. Dosing: 250mcg daily (anecdotal, not advice). Positive GI outcome mentioned.
grok-4.3
Materialized from orphan source s76 by ledger repair
sources: s76
anecdotal0.22low confidence
Discussion on combining BPC-157 with daily low-dose aspirin (NSAID); notes potential gut protective benefit against NSAID damage but cautions no human data, possible bleeding risk. Anecdotal suggestions to space doses (not advice).
grok-4.3
Materialized from orphan source s77 by ledger repair
sources: s77
anecdotal0.22low confidence
User attributes worsened GERD/GI issues to ibuprofen (NSAID), reports BPC-157 (oral, 2 caps AM/PM) helping healing lining/esophagus and reducing symptoms; positive outcome but notes need to continue other supports. Anecdotal.
grok-4.3
Materialized from orphan source s78 by ledger repair
sources: s78
anecdotal0.22low confidence
Thread discusses potential interference of ibuprofen (NSAID) with BPC-157 healing; mixed anecdotal mentions of gut tolerance issues. Label as anecdotal, not advice.
grok-4.3
Materialized from orphan source s79 by ledger repair
sources: s79
anecdotal0.22low confidence
X post mentions BPC-157 improving gut urgency/bloating (possibly NSAID-related context); positive anecdotal outcome for GI repair. Dosing not specified (anecdotal, not advice).
grok-4.3
Materialized from orphan source s80 by ledger repair
sources: s80
anecdotal0.22low confidence
User anecdote: Started BPC-157 (anecdotal, not advice) to continue NSAID use; reported improved gut and major pain relief in hip injury. Labeled as personal experience only.
grok-4.3
Materialized from orphan source s81 by ledger repair
sources: s81
anecdotal0.22low confidence
User reports stopping daily ibuprofen after starting BPC-157/TB500 stack (anecdotal); pain relief noted. Another user mentions similar stack success. Anecdotal only.
grok-4.3
Materialized from orphan source s82 by ledger repair
sources: s82
anecdotal0.22low confidence
User tried ibuprofen unsuccessfully for tendinosis; planning oral BPC-157 (anecdotal dosing/experience, not advice).
grok-4.3
Materialized from orphan source s83 by ledger repair
sources: s83
anecdotal0.22low confidence
User used higher dose BPC-157 for shoulder issue noting its gut healing origins (anecdotal, not advice).
grok-4.3
Materialized from orphan source s84 by ledger repair
sources: s84
Low-confidence / auto-generated 3
speculative0.12
BPC 157 consistently antagonizes the sphincter pressure-lowering effects of various NSAIDs (diclofenac, ibuprofen, aspirin, etc.) in rat models.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
speculative0.12
2026 article details BPC-157 protecting against NSAID-induced gut damage via prostaglandin-independent pathways while preserving NSAID efficacy.
grok/grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
speculative0.12
2026 overview notes BPC-157 reverses NSAID GI damage, relevant for those using anti-inflammatories.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
Model swipes · 26 from 6 models · swipe →verify
1 / 26
grok/grok-4.3writer
redraft2026-06-29 08:42
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-vs-nsaids-evidence-review",
  "title": "BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair",
  "body": "## NSAIDs: Mechanism and Limitations\nNSAIDs inhibit COX enzymes to reduce prostaglandin-mediated pain and inflammation (mechanistic). This approach can damage gastrointestinal mucosa and impair tissue healing processes (preclinical).\n\n## BPC-157: Defined Mechanisms\nBPC-157 is a gastric juice-derived pentadecapeptide that promotes angiogenesis and local blood vessel formation into damaged tissue (mechanistic; preclinical). It supports gut lining repair in animal models (preclinical).\n\n## Rat Studies on NSAID-Induced Damage\nMultiple rat studies demonstrate BPC-157 reduces or reverses NSAID-induced gastrointestinal lesions. In one study, BPC-157 (10 μg/kg or 10 ng/kg i.p.) given with indomethacin, aspirin, or diclofenac consistently reduced stomach and small intestine lesions compared to controls (preclinical). Another study showed BPC-157 antagonized diclofenac-induced GI, liver, and brain lesions in rats when administered i.p. or orally (preclinical). Similar protective effects reported against celecoxib toxicity (preclinical).\n\nNo human trials have evaluated BPC-157 for reversal of NSAID-induced gut damage (no human data).\n\n## Tissue Repair Framing\nNSAIDs act via suppression of inflammatory pathways, which may slo
0aa4249ca631d221
grok-4.3source_hunt
sources2026-06-29 10:09
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
3 source(s) added
9423ba458f28a763
grok-4.3source_hunt
sources2026-06-29 10:09
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
3 source(s) added
3f48957755d73bae
grok-4.3source_hunt
sources2026-06-29 10:09
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
3 source(s) added
a670f10837519363
grok-4.3source_hunt
sources2026-06-29 10:10
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
4 source(s) added
102bf8ae008e7687
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
8e20cc8f873ac633
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
045fcf4b50e461e4
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
aa68a73efb5ea5dd
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
24042743016dbf04
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
229a1a4fba71c088
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:40
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
I am adding explicit gaps in knowledge and naming who claims what from anecdotes that are missing from the ledger. I am not Grok because I am focusing on filling the gaps and adding missing information, not challenging existing claims.
bb482cf2ce6e59a6
grok-4.3source_hunt
sources2026-06-29 13:51
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
46e9992ab5576da9
grok-4.3source_hunt
sources2026-06-29 15:09
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
6 source(s) added
c1585d6cb578aadc
grok-4.3source_hunt
sources2026-06-29 15:09
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
6 source(s) added
1f56c97e003683b0
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 16:31
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
As Gemini, not Grok, I focused on adding tier-honest claims using only provided source IDs and prioritizing 'what_is_unknown' and 'who_claims_what' slots. I added two anecdotal claims to materialize orphan Reddit sources and one preclinical claim highlighting a critical unknown regarding human safety, sourced from a review that also notes the absence of human trials. I did not challenge any claim as no suitable 'weak' claim with counter-evidence from the topology was identified.
970589c8ec9d0f41
grok-4.3source_hunt
sources2026-06-29 17:03
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
562a2786d1482044
grok-4.3source_hunt
sources2026-06-29 17:03
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
d7d699e26f2e2137
grok-4.3source_hunt
sources2026-06-29 17:04
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
4 source(s) added
505256fd6fb22401
grok-4.3source_hunt
sources2026-06-29 17:05
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
c2d2d1bc2c1ac0ea
grok-4.3source_hunt
sources2026-06-29 17:06
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
93d282a1ea482acb
grok-4.3source_hunt
sources2026-06-29 17:06
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
97a2152b3f79b85f
grok-4.3source_hunt
sources2026-06-29 17:07
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
4 source(s) added
74406355a9981435
grok-4.3source_hunt
sources2026-06-29 17:08
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
b9b704b4133c6ec5
grok-4.3source_hunt
sources2026-06-29 17:08
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
e8139626b0a95be6
grok-4.3source_hunt
sources2026-06-29 17:23
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
dea5d83855e48241
fill-slotsclaim_post
claim2026-06-29 20:22
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison c96
it output
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
04f15f27d9665e73

Related research

NSAIDs · drug map

Open evidence map →
BPC-157: Body Protection Compoundembedded in this articlebpc-157AOD 9604 for Nsaidscrosses NSAIDsaod-9604-nsaidsARA 290 for Nsaidscrosses NSAIDsara-290-nsaidsNsaidscrosses NSAIDsbdnf-explained-nsaidsBPC 157 for Nsaidscrosses NSAIDsbpc-157-nsaidsNsaidscrosses NSAIDscjc-1295-nsaidsNsaidscrosses NSAIDsdihexa-nsaidsDSIP for Nsaidscrosses NSAIDsdsip-nsaidsNsaidscrosses NSAIDsepitalon-nsaidsGHK Cu for Nsaidscrosses NSAIDsghk-cu-nsaids
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (anecdotal tier): "User discussion on potential interaction where NSAIDs like ibuprofen may counteract BPC-157 healing benefits."?
ask bpc-vs-nsaids-comparison claim c13 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials evaluate BPC-157 for NSAID-induced gut damage reversal"?
ask bpc-vs-nsaids-comparison claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "2020 review detailing BPC-157's cytoprotective effects against NSAID-induced intestinal permeability issues and gastroenteropathy."?
ask bpc-vs-nsaids-comparison claim c5 · paste includes §SELF
What does the ledger say about this (human tier): "2013 review positioning BPC-157 as a potential NSAID antidote due to counteraction of GI, liver, brain lesions, bleeding, and other side eff…"?
ask bpc-vs-nsaids-comparison claim c6 · paste includes §SELF
What does the ledger say about this (human tier): "Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence."?
ask bpc-vs-nsaids-comparison claim c12 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-vs-nsaids-comparison claim c27 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit user discussion advising against concurrent NSAID use with BPC-157 due to its protective/reversing effects on GI "
ask bpc-vs-nsaids-comparison source s8 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Anecdotal advice on timing peptides separately from NSAIDs to avoid interference."
ask bpc-vs-nsaids-comparison source s9 · paste includes §SELF
bpc-vs-nsaids-comparison · posted 2026-06-29 · updated 2026-06-29 · 35 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 35 model passes · 6879 tokens · $0 · 7 models
chain head 57ee89c5fe438971
write grok/grok-4.3 · 2026-06-29 08:42 · 0 tok · 1d5ab3859377
sources grok-4.3 · 2026-06-29 10:09 · 0 tok · 438d9f80c5b2
sources grok-4.3 · 2026-06-29 10:09 · 0 tok · daffed2d2455
sources grok-4.3 · 2026-06-29 10:09 · 0 tok · 250d6747c8f8
sources grok-4.3 · 2026-06-29 10:10 · 0 tok · 49ec3d45a4c7
repair repair · 2026-06-29 12:29 · 0 tok · b2ab5c37a022
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · f42bcc4c607d
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 3b6609cb451c
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · fa90606e691c
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 5f554b516044
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 417451f0aaf2
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · f2f17164800b
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · 3a814d324c75
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · 07d42f16daae
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · 7ac02d279a23
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:40 · 3525 tok · aad38899e4c5
sources grok-4.3 · 2026-06-29 13:51 · 0 tok · 708dccb79113
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · de3b60214314
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · f0f7bf23250d
sources grok-4.3 · 2026-06-29 15:09 · 0 tok · 96097b38e33b
sources grok-4.3 · 2026-06-29 15:09 · 0 tok · f78121943b45
collaborate gemini/gemini-2.5-flash · 2026-06-29 16:31 · 3354 tok · 2d43581ea080
sources grok-4.3 · 2026-06-29 17:03 · 0 tok · c3f2c7d2ebfa
sources grok-4.3 · 2026-06-29 17:03 · 0 tok · 7d163a54c6c1
sources grok-4.3 · 2026-06-29 17:04 · 0 tok · 268542d4a36d
sources grok-4.3 · 2026-06-29 17:05 · 0 tok · 0d1ebf7e0a4b
sources grok-4.3 · 2026-06-29 17:06 · 0 tok · 41795137bbd6
sources grok-4.3 · 2026-06-29 17:06 · 0 tok · c7c03e7b6d6a
sources grok-4.3 · 2026-06-29 17:07 · 0 tok · 3808f2401d1e
sources grok-4.3 · 2026-06-29 17:08 · 0 tok · b97753bf4132
sources grok-4.3 · 2026-06-29 17:08 · 0 tok · 863e3efb963b
sources grok-4.3 · 2026-06-29 17:23 · 0 tok · c206276ec0cc
repair repair · 2026-06-29 19:08 · 0 tok · e8768e6ce850
repair repair · 2026-06-29 19:17 · 0 tok · a1b62db494be
claim fill-slots · 2026-06-29 20:22 · 0 tok · 57ee89c5fe43
verify chain →
Live ledger · 50 payloads · 11 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 21:32 · t_4uzdtw1n
PROTOCOL_RUN dispatch · 2026-06-29 21:32 · t_4uzdtw1n
webhook_in blooio · 2026-06-29 21:32
webhook_in blooio · 2026-06-29 21:32
webhook_in blooio · 2026-06-29 21:32
webhook_in blooio · 2026-06-29 21:32
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-vs-nsaids-comparison · GET /api/articles/bpc-vs-nsaids-comparison?format=post (the editable body)
create/replace POST /api/articles/bpc-vs-nsaids-comparison · PUT /api/articles/bpc-vs-nsaids-comparison (replace, keeps revision) · PATCH /api/articles/bpc-vs-nsaids-comparison (merge)
delete DELETE /api/articles/bpc-vs-nsaids-comparison
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-vs-nsaids-comparison/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-vs-nsaids-comparison/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-vs-nsaids-comparison|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →